Change language dansk English suomi svenska

Generate Estimates Confirm Cancel Hide empty rows Show hidden rows DummyText

NEODENT DENTALLABORATORIUM ApS Estimate generation in progress, please wait... 0%

Quicksearch from your own companies XBRLDenmark Analyst: XBRLDenmark

Loading... Loading... Loading... Loading... Loading... Loading... Loading...

1000.0 Bankruptcy Risk  2018 2018/12 2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024e N/A 2025e N/A Bankruptcy risk for industry   1.5% 1.5% 1.5% 1.5% 1.5% 1.5% 1.5% 0.5%   Bankruptcy risk   34.3% 16.7% 16.8% 20.1% 13.1% 14.9% 20.7% 15.9%   Credit score (0-100)   1 11 10 5 17 13 5 12   Credit rating   C BB BB B BB BB B BB   Credit limit (kDKK)   -0.0 -0.0 -0.0 -0.0 -0.0 -0.0 -0.0 -0.0   How are these values calculated?   View the automatically generated explanation of bankruptcy risk 1000.0 Income statement (kDKK)  2018 2018/12 2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024e N/A 2025e N/A Net sales   634 478 477 394 0 0 0 0   Gross profit   239 144 267 223 92.0 21.2 0.0 0.0   EBITDA   -22.2 -76.1 18.9 45.2 -45.6 -101 0.0 0.0   EBIT   -37.1 -79.8 18.9 45.2 -45.6 -101 0.0 0.0   Pre-tax profit (PTP)   -37.2 -79.8 17.4 43.8 -46.7 -102.6 0.0 0.0   Net earnings   -37.2 -79.8 15.1 43.8 -46.7 -102.6 0.0 0.0   Pre-tax profit without non-rec. items   -37.2 -79.8 17.4 43.8 -46.7 -103 0.0 0.0     See the entire income statement 1000.0 Balance sheet (kDKK)  2018 2018/12 2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024e N/A 2025e N/A Tangible assets total   3.7 0.0 50.1 50.1 34.0 0.0 0.0 0.0   Shareholders equity total   -324 -293 -278 -246 -281 -384 -509 -509   Interest-bearing liabilities   0.0 0.0 0.0 0.0 358 393 509 509   Balance sheet total (assets)   31.2 114 136 103 76.6 16.0 0.0 0.0   Net Debt   -7.8 -33.6 -15.8 -11.5 357 385 509 509     See the entire balance sheet 1000.0 Volume  2018 2018/12 2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024e N/A 2025e N/A Net sales   634 478 477 394 0 0 0 0   Net sales growth   0.0% -24.6% -0.1% -17.5% -100.0% 0.0% 0.0% 0.0%   Gross profit   239 144 267 223 92.0 21.2 0.0 0.0   Gross profit growth   -47.0% -39.8% 85.5% -16.6% -58.7% -76.9% -100.0% 0.0%   Employees   0 0 0 0 0 0 0 0   Employee growth %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Employee expenses   0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0   Balance sheet total (assets)   31 114 136 103 77 16 0 0   Balance sheet change%   0.0% 267.3% 19.2% -24.7% -25.5% -79.0% -100.0% 0.0%   Added value   -22.2 -76.1 18.9 45.2 -45.6 -100.6 0.0 0.0   Added value %   -3.5% -15.9% 4.0% 11.5% 0.0% 0.0% 0.0% 0.0%   Investments   -11 -7 50 0 -16 -34 0 0   Net sales trend   0.0 -1.0 -2.0 -3.0 -4.0 0.0 0.0 0.0   EBIT trend   -1.0 -2.0 1.0 2.0 -1.0 -2.0 0.0 0.0   1000.0 Profitability  2018 2018/12 2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024e N/A 2025e N/A EBITDA %   -3.5% -15.9% 4.0% 11.5% 0.0% 0.0% 0.0% 0.0%   EBIT %   -5.9% -16.7% 4.0% 11.5% 0.0% 0.0% 0.0% 0.0%   EBIT to gross profit (%)   -15.5% -55.4% 7.1% 20.3% -49.5% -473.6% 0.0% 0.0%   Net Earnings %   -5.9% -16.7% 3.2% 11.1% 0.0% 0.0% 0.0% 0.0%   Profit before depreciation and extraordinary items %   -3.5% -15.9% 3.2% 11.1% 0.0% 0.0% 0.0% 0.0%   Pre tax profit less extraordinaries %   -5.9% -16.7% 3.6% 11.1% 0.0% 0.0% 0.0% 0.0%   ROA %   -10.4% -20.9% 4.6% 11.9% -12.9% -26.6% 0.0% 0.0%   ROI %   0.0% 0.0% 0.0% 0.0% -25.5% -26.8% 0.0% 0.0%   ROE %   -119.4% -109.6% 12.0% 36.6% -52.1% -221.6% 0.0% 0.0%   1000.0 Solidity  2018 2018/12 2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024e N/A 2025e N/A Equity ratio %   -91.2% -71.9% -67.1% -70.5% -78.6% -96.0% -100.0% -100.0%   Relative indebtedness %   56.1% 85.3% 86.9% 88.6% 0.0% 0.0% 0.0% 0.0%   Relative net indebtedness %   54.8% 78.3% 83.6% 85.7% 0.0% 0.0% 0.0% 0.0%   Net int. bear. debt to EBITDA, %   35.0% 44.2% -83.7% -25.5% -782.9% -382.9% 0.0% 0.0%   Gearing %   0.0% 0.0% 0.0% 0.0% -127.2% -102.4% -100.0% -100.0%   Net interest   0 0 0 0 0 0 0 0   Financing costs %   0.0% 0.0% 0.0% 0.0% 0.7% 0.5% 0.0% 0.0%   1000.0 Liquidity  2018 2018/12 2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024e N/A 2025e N/A Quick Ratio   -0.1 0.2 0.1 0.1 0.1 0.0 0.0 0.0   Current Ratio   0.1 0.3 0.2 0.2 0.1 0.0 0.0 0.0   Cash and cash equivalent   7.8 33.6 15.8 11.5 0.9 7.6 0.0 0.0   1000.0 Capital use efficiency  2018 2018/12 2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024e N/A 2025e N/A Trade debtors turnover (days)   -23.3 14.2 25.2 16.7 0.0 0.0 0.0 0.0   Trade creditors turnover (days)   0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0   Current assets / Net sales %   4.3% 24.0% 18.1% 13.4% 0.0% 0.0% 0.0% 0.0%   Net working capital   -328.0 -293.3 -326.0 -296.3 -315.1 -383.7 -254.4 -254.4   Net working capital %   -51.7% -61.4% -68.3% -75.2% 0.0% 0.0% 0.0% 0.0%   1000.0 Employee efficiency  2018 2018/12 2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024e N/A 2025e N/A Net sales / employee   0 0 0 0 0 0 0 0   Added value / employee   0 0 0 0 0 0 0 0   Employee expenses / employee   0 0 0 0 0 0 0 0   EBITDA / employee   0 0 0 0 0 0 0 0   EBIT / employee   0 0 0 0 0 0 0 0   Net earnings / employee   0 0 0 0 0 0 0 0